BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 15650227)

  • 1. G-->A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo.
    Kieffer TL; Kwon P; Nettles RE; Han Y; Ray SC; Siliciano RF
    J Virol; 2005 Feb; 79(3):1975-80. PubMed ID: 15650227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resting CD4+ T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes.
    Han Y; Lassen K; Monie D; Sedaghat AR; Shimoji S; Liu X; Pierson TC; Margolick JB; Siliciano RF; Siliciano JD
    J Virol; 2004 Jun; 78(12):6122-33. PubMed ID: 15163705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure.
    Ruff CT; Ray SC; Kwon P; Zinn R; Pendleton A; Hutton N; Ashworth R; Gange S; Quinn TC; Siliciano RF; Persaud D
    J Virol; 2002 Sep; 76(18):9481-92. PubMed ID: 12186930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4(+) T cells.
    Janini M; Rogers M; Birx DR; McCutchan FE
    J Virol; 2001 Sep; 75(17):7973-86. PubMed ID: 11483742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells.
    Chiu YL; Soros VB; Kreisberg JF; Stopak K; Yonemoto W; Greene WC
    Nature; 2005 May; 435(7038):108-14. PubMed ID: 15829920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus (HIV) type 1 proviral hypermutation correlates with CD4 count in HIV-infected women from Kenya.
    Land AM; Ball TB; Luo M; Pilon R; Sandstrom P; Embree JE; Wachihi C; Kimani J; Plummer FA
    J Virol; 2008 Aug; 82(16):8172-82. PubMed ID: 18550667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel assay allows genotyping of the latent reservoir for human immunodeficiency virus type 1 in the resting CD4+ T cells of viremic patients.
    Monie D; Simmons RP; Nettles RE; Kieffer TL; Zhou Y; Zhang H; Karmon S; Ingersoll R; Chadwick K; Zhang H; Margolick JB; Quinn TC; Ray SC; Wind-Rotolo M; Miller M; Persaud D; Siliciano RF
    J Virol; 2005 Apr; 79(8):5185-202. PubMed ID: 15795302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of evidence for protease evolution in HIV-1-infected patients after 2 years of successful highly active antiretroviral therapy.
    Parera M; Ibañez A; Clotet B; Martinez MA
    J Infect Dis; 2004 Apr; 189(8):1444-51. PubMed ID: 15073682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo.
    de Baar MP; Janssens W; de Ronde A; Fransen K; Colebunders R; Kestens L; van der Groen G; Goudsmit J
    AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1385-94. PubMed ID: 11018858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly active antiretroviral therapy failure and protease and reverse transcriptase human immunodeficiency virus type 1 gene mutations.
    Monno L; Appice A; Cavaliere R; Scarabaggio T; Angarano G
    J Infect Dis; 1999 Aug; 180(2):568-71. PubMed ID: 10395885
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of human immunodeficiency virus type 1 transcriptional elongation in resting CD4+ T cells in vivo.
    Lassen KG; Bailey JR; Siliciano RF
    J Virol; 2004 Sep; 78(17):9105-14. PubMed ID: 15308706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells.
    Bailey JR; Sedaghat AR; Kieffer T; Brennan T; Lee PK; Wind-Rotolo M; Haggerty CM; Kamireddi AR; Liu Y; Lee J; Persaud D; Gallant JE; Cofrancesco J; Quinn TC; Wilke CO; Ray SC; Siliciano JD; Nettles RE; Siliciano RF
    J Virol; 2006 Jul; 80(13):6441-57. PubMed ID: 16775332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CD4+ and CD8+ T-lymphocyte counts in human immunodeficiency virus type 1 subtype A-infected patients carrying mutations V77I in protease and/or A62V in reverse transcriptase].
    Selimova LM; Serebrovskaia LV; Ivanova LA; Nosik DN
    Vopr Virusol; 2010; 55(2):22-6. PubMed ID: 20455467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples.
    Venturi G; Catucci M; Romano L; Corsi P; Leoncini F; Valensin PE; Zazzi M
    J Infect Dis; 2000 Feb; 181(2):740-5. PubMed ID: 10669367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational resistance pattern of HIV type 1 in CD14+ monocytes, CD4+ T cells, and plasma from treated patients.
    Turriziani O; Boni A; Falasca F; Graziano F; Bucci M; D'Ettorre G; Fantauzzi A; Paoletti F; Massetti AP; Mezzaroma I; Antonelli G
    AIDS Res Hum Retroviruses; 2010 Jun; 26(6):625-34. PubMed ID: 20507206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus type 1 (HIV-1) antigen secretion by latently infected resting CD4+ T lymphocytes from HIV-1-infected individuals.
    Fondere JM; Petitjean G; Huguet MF; Salhi SL; Baillat V; Macura-Biegun A; Becquart P; Reynes J; Vendrell JP
    J Virol; 2004 Oct; 78(19):10536-42. PubMed ID: 15367620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sexual transmission of HIV-1 isolate showing G-->A hypermutation.
    Caride E; Brindeiro RM; Kallas EG; de Sá CA; Eyer-Silva WA; Machado E; Tanuri A
    J Clin Virol; 2002 Jan; 23(3):179-89. PubMed ID: 11595597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of human immunodeficiency virus type 1 decay following entry into resting CD4+ T cells.
    Zhou Y; Zhang H; Siliciano JD; Siliciano RF
    J Virol; 2005 Feb; 79(4):2199-210. PubMed ID: 15681422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes.
    Pariente N; Pernas M; de la Rosa R; Gómez-Mariano G; Fernández G; Rubio A; López M; Benito JM; López-Galíndez C; Leal M; Domingo E; Martinez MA; Mas A
    J Med Virol; 2004 Jul; 73(3):350-61. PubMed ID: 15170628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the reverse transcriptase and protease genes of human immunodeficiency virus-1 from antiretroviral naïve and treated pediatric patients.
    Bure D; Makhdoomi MA; Lodha R; Prakash SS; Kumar R; Parray HA; Singh R; Kabra SK; Luthra K
    Viruses; 2015 Feb; 7(2):590-603. PubMed ID: 25674767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.